Objective Observational studies have shown an association between COVID‐19 and
epilepsy. However, causality remains unproven. This study aimed to investigate the …

Objectives We aimed to describe the trajectories of cognitive and physical symptoms before,
during, and after a positive-or negative SARS-CoV-2 test and in untested controls. Design A …

Purpose: There have been several reports of central nervous system impairments
associated with severe coronavirus disease 2019 (COVID-19) infection on head magnetic …

Accumulating evidence indicates that coronavirus disease 2019 is a major cause of
delirium. Given the global dimension of the current pandemic and the fact that delirium is a …

Résumé Les manifestations et complications neurologiques de la phase aiguë de la Covid-
19 sont nombreuses. Elles concernent principalement le système nerveux central sous les …

COVID-19 remains a significant clinical issue worldwide, with frequent neurological
manifestations. In this study, the authors combine data obtained from the patient's medical …

Objective To assess risk factors for encephalopathy in non-ICU hospitalized patients with
COVID-19 and the effect of encephalopathy on short-term outcomes. Methods We collected …

Patients with coronavirus disease 2019 (COVID-19) infection can suffer from a variety of
neurological disorders; therefore, there is a demand to investigate specific treatments. As a …

According to best current estimates, approximately 10% of those infected with SARS-CoV-2-
virus experience long-term clinical and nonspecific neurological symptoms that may last for …

On the threshold of the COVID outbreak; electroencephalography (EEG) was used in
diagnosis, crossborder disease differential diagnosis, disease-staging, monitoring of …